KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). Supplied as compressed tablets for laboratory research applications, KPV is utilized in preclinical investigations examining melanocortin receptor signaling.

Chemical/Compound Information:

• Chemical Name: Lysine-Proline-Valine tripeptide
• Molecular Formula: C14H27N5O4
• Molecular Weight: 317.39 g/mol
• Compound Class: Alpha-MSH Fragment Peptide

KPV represents a minimal functional epitope of α-MSH and serves as a model compound for studying melanocortin-1 (MC1R) receptor activation pathways. The compressed tablet formulation supports consistent dosing in in-vitro receptor binding assays and cell culture models investigating melanocortin signaling cascades.

Research Applications:

• MC1R receptor pharmacology studies and competitive binding kinetics
• Melanocortin signaling cascade investigation in mammalian cell lines
• Comparative peptide structure-activity relationship (SAR) analysis
• Receptor internalization and trafficking studies using epitope-tagged variants
• Immunomodulatory peptide screening applications

Storage and Handling:

• Store at 2-8°C in original sealed tablet bottle away from moisture
• Protect from direct light exposure; use opaque storage containers
• Maintain in controlled-humidity environment (40-60% RH)
• Verify seal integrity prior to use; discontinue if seal is compromised

Product Specifications:

• Purity: ≥95% (HPLC)
• Appearance: White to off-white compressed tablets
• Form: Compressed tablets
• Quantity: 100 tablets × 5mg each (500mcg active per tablet equivalent dosing)

FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.